<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Microbiological Research</journalTitle>
<eissn>2328-4137</eissn>
<publicationDate>2025-12-04</publicationDate>
<volume>13</volume>
<issue>6</issue>
<startPage>130</startPage>
<endPage>136</endPage>
<doi>10.12691/ajmr-13-6-2</doi>
<publisherRecordId>AJMR20251362</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Bacterial Ecology and Antimicrobial Resistance Patterns in the Chemotherapy Ward of CNRAO, C&#244;te d¡¯Ivoire: A Sub-Saharan Experience</title>
<authors>
<author>
<name>Boni Catherine</name>
<affiliationId>1</affiliationId>
<affiliationId>2</affiliationId>
</author>
<author>
<name>Yapi Adompo Jaur¨¨s Cedric</name>
<email>yapijaures@yahoo.fr</email>
<affiliationId>3</affiliationId>
<affiliationId>3</affiliationId>
</author>
<author>
<name>M¨¦it¨¦ Syndou</name>
<affiliationId>3</affiliationId>
<affiliationId>3</affiliationId>
</author>
<author>
<name>Yapi Ivanne Alexia</name>
<affiliationId>3</affiliationId>
</author>
<author>
<name>Gnegouri Rachelle</name>
<affiliationId>3</affiliationId>
</author>
<author>
<name>Bahan Gninissemet Armel</name>
<affiliationId>3</affiliationId>
</author>
<author>
<name>Koffi Stephane</name>
<affiliationId>3</affiliationId>
</author>
<author>
<name>Kacou-N¡¯douba Ad¨¨le</name>
<affiliationId>3</affiliationId>
</author>
<author>
<name>Kouassi-M¡¯bengue Alphonsine</name>
<affiliationId>3</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Medical Biology Laboratory, Alassane Ouattara National Centre for Medical Oncology and Radiotherapy (CNRAO), Abidjan, C?te d¡¯Ivoire</affiliationName>
<affiliationName affiliationId="3">Bacteriology-Virology Laboratory, Yopougon University Hospital, Abidjan, C?te d¡¯Ivoire</affiliationName>







</affiliationsList>
<abstract language="eng">Background: Cancer patients receiving chemotherapy are highly vulnerable to environmental infections due to treatment-induced immunosuppression, yet bacterial contamination and antibiotic resistance patterns in African oncology facilities remain uncharacterized. We conducted a comprehensive environmental surveillance of a West African chemotherapy unit to identify infection risks threatening these vulnerable patients. Methods: We collected 39 environmental samples (36 surfaces, 3 air) from high-touch sites across the chemotherapy unit at Centre National de Radioth&#233;rapie et d'Oncologie M&#233;dicale Alassane Ouattara (August-October 2024). Bacterial isolates underwent identification using conventional methods and API systems, with antimicrobial susceptibility testing by Kirby-Bauer disk diffusion under EUCAST 2023 guidelines. Extended-spectrum ¦Â-lactamase (ESBL) production was confirmed by double-disk synergy testing. Results: Surface contamination occurred in 63.9% of samples; air remained sterile. Twenty-nine isolates recovered: Bacillus spp. (34.5%), coagulase-negative staphylococci (27.6%), Pseudomonas aeruginosa (20.7%), Enterobacteriaceae (17.2%). Water sources harbored Pseudomonas and ESBL-producers. Resistance was substantial: 40% Enterobacteriaceae produced ESBLs with fluoroquinolone co-resistance, 14.3% coagulase-negative staphylococci exhibited methicillin/aminoglycoside resistance, all P. aeruginosa (6/6) showed intermediate colistin susceptibility. Bacillus demonstrated aminopenicillin resistance but carbapenem susceptibility. No carbapenemase-producers detected. Conclusions: This chemotherapy unit surveillance reveals concerning environmental contamination with resistant opportunistic pathogens. Bacillus predominance and water-associated Pseudomonas/ESBL-Enterobacteriaceae colonization highlight unique tropical ecology patterns. Enhanced cleaning protocols, water system management, and antimicrobial stewardship adapted to local resistance are urgently needed. These baseline data inform infection prevention programs protecting vulnerable African cancer patients.</abstract>
<fullTextUrl format="pdf">https://pubs.sciepub.com/ajmr/13/6/2/ajmr-13-6-2.pdf</fullTextUrl>
<keywords language="eng"><keyword>Antimicrobial resistance</keyword>
<keyword>Environmental surveillance</keyword>
<keyword>Healthcare-associated infections</keyword>
<keyword>Sub-Saharan Africa</keyword>
<keyword>C?te d¡¯Ivoire</keyword>
</keywords>
</record>
</records>
